Interdisciplinary, Multi-institutional, Revolutionary
Who We Are
The Neurodegeneration Consortium (NDC) is a science-driven multi-institutional initiative established with a goal to advance the study and drug discovery of Alzheimer’s disease and other neurodegenerative disorders.
The NDC leverages the unique infrastructure and world-class scientific and translational talent of the University of Texas MD Anderson Cancer Center, Baylor College of Medicine, Massachusetts Institute of Technology’s (MIT)- the Picower Insititute for Learning and Memory and Whitehead Institute for Biomedical Research. This collaborative endeavor between the institutions facilitates innovation and accelerates our drug discovery efforts.
The NDC has been making a difference since its inception in October 2012 with a generous philanthropic donations from the Belfer Family Foundation and donors to the University of Texas MD Anderson Cancer Center, Baylor College of Medicine and Massachusetts Institute of Technology’s (MIT).
The NDC adopts a transformative hybrid environment by bringing together experts and leaders in the field with experience that spans the entire continuum – from understanding the underlying biology to the discovery of new targets; from finding the molecules that are effective on these tragets to translating these drug-like molecules into effective therapies for our patients.